385 related articles for article (PubMed ID: 30315128)
1. Transynaptic Action of Botulinum Neurotoxin Type A at Central Cholinergic Boutons.
Caleo M; Spinelli M; Colosimo F; Matak I; Rossetto O; Lackovic Z; Restani L
J Neurosci; 2018 Nov; 38(48):10329-10337. PubMed ID: 30315128
[TBL] [Abstract][Full Text] [Related]
2. Long-distance retrograde effects of botulinum neurotoxin A.
Antonucci F; Rossi C; Gianfranceschi L; Rossetto O; Caleo M
J Neurosci; 2008 Apr; 28(14):3689-96. PubMed ID: 18385327
[TBL] [Abstract][Full Text] [Related]
3. Evidence for anterograde transport and transcytosis of botulinum neurotoxin A (BoNT/A).
Restani L; Antonucci F; Gianfranceschi L; Rossi C; Rossetto O; Caleo M
J Neurosci; 2011 Nov; 31(44):15650-9. PubMed ID: 22049408
[TBL] [Abstract][Full Text] [Related]
4. Direct central nervous system effects of botulinum neurotoxin.
Caleo M; Restani L
Toxicon; 2018 Jun; 147():68-72. PubMed ID: 29111119
[TBL] [Abstract][Full Text] [Related]
5. More than at the neuromuscular synapse: actions of botulinum neurotoxin A in the central nervous system.
Mazzocchio R; Caleo M
Neuroscientist; 2015 Feb; 21(1):44-61. PubMed ID: 24576870
[TBL] [Abstract][Full Text] [Related]
6. Botulinum neurotoxin A impairs neurotransmission following retrograde transynaptic transport.
Restani L; Novelli E; Bottari D; Leone P; Barone I; Galli-Resta L; Strettoi E; Caleo M
Traffic; 2012 Aug; 13(8):1083-9. PubMed ID: 22519601
[TBL] [Abstract][Full Text] [Related]
7. Use-dependent potentiation of voltage-gated calcium channels rescues neurotransmission in nerve terminals intoxicated by botulinum neurotoxin serotype A.
Beske PH; Hoffman KM; Machamer JB; Eisen MR; McNutt PM
Sci Rep; 2017 Nov; 7(1):15862. PubMed ID: 29158500
[TBL] [Abstract][Full Text] [Related]
8. Exchanging the minimal cell binding fragments of tetanus neurotoxin in botulinum neurotoxin A and B impacts their toxicity at the neuromuscular junction and central neurons.
Höltje M; Schulze S; Strotmeier J; Mahrhold S; Richter K; Binz T; Bigalke H; Ahnert-Hilger G; Rummel A
Toxicon; 2013 Dec; 75():108-21. PubMed ID: 23817019
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic effectiveness of botulinum neurotoxin A: potent blockade of autonomic transmission by targeted cleavage of only the pertinent SNAP-25.
Lawrence GW; Ovsepian SV; Wang J; Aoki KR; Dolly JO
Neuropharmacology; 2013 Jul; 70():287-95. PubMed ID: 23485402
[TBL] [Abstract][Full Text] [Related]
10. Persistence of botulinum neurotoxin A demonstrated by sequential administration of serotypes A and E in rat EDL muscle.
Adler M; Keller JE; Sheridan RE; Deshpande SS
Toxicon; 2001; 39(2-3):233-43. PubMed ID: 10978741
[TBL] [Abstract][Full Text] [Related]
11. Presynaptic protein interactions in vivo: evidence from botulinum A, C, D and E action at frog neuromuscular junction.
Raciborska DA; Trimble WS; Charlton MP
Eur J Neurosci; 1998 Aug; 10(8):2617-28. PubMed ID: 9767392
[TBL] [Abstract][Full Text] [Related]
12. Mastoparan-7 rescues botulinum toxin-A poisoned neurons in a mouse spinal cord cell culture model.
Zhang P; Ray R; Singh BR; Ray P
Toxicon; 2013 Dec; 76():37-43. PubMed ID: 24047963
[TBL] [Abstract][Full Text] [Related]
13. Evidence for central antispastic effect of botulinum toxin type A.
Matak I
Br J Pharmacol; 2020 Jan; 177(1):65-76. PubMed ID: 31444910
[TBL] [Abstract][Full Text] [Related]
14. Botulinum neurotoxin C mutants reveal different effects of syntaxin or SNAP-25 proteolysis on neuromuscular transmission.
Zanetti G; Sikorra S; Rummel A; Krez N; Duregotti E; Negro S; Henke T; Rossetto O; Binz T; Pirazzini M
PLoS Pathog; 2017 Aug; 13(8):e1006567. PubMed ID: 28800600
[TBL] [Abstract][Full Text] [Related]
15. Botulinum neurotoxins A and E undergo retrograde axonal transport in primary motor neurons.
Restani L; Giribaldi F; Manich M; Bercsenyi K; Menendez G; Rossetto O; Caleo M; Schiavo G
PLoS Pathog; 2012 Dec; 8(12):e1003087. PubMed ID: 23300443
[TBL] [Abstract][Full Text] [Related]
16. Control of autophagosome axonal retrograde flux by presynaptic activity unveiled using botulinum neurotoxin type a.
Wang T; Martin S; Papadopulos A; Harper CB; Mavlyutov TA; Niranjan D; Glass NR; Cooper-White JJ; Sibarita JB; Choquet D; Davletov B; Meunier FA
J Neurosci; 2015 Apr; 35(15):6179-94. PubMed ID: 25878289
[TBL] [Abstract][Full Text] [Related]
17. Syntaxin and 25-kDa synaptosomal-associated protein: differential effects of botulinum neurotoxins C1 and A on neuronal survival.
Williamson LC; Neale EA
J Neurosci Res; 1998 Jun; 52(5):569-83. PubMed ID: 9632313
[TBL] [Abstract][Full Text] [Related]
18. BoNT/A in the Urinary Bladder-More to the Story than Silencing of Cholinergic Nerves.
Ibrahim H; Maignel J; Hornby F; Daly D; Beard M
Toxins (Basel); 2022 Jan; 14(1):. PubMed ID: 35051030
[TBL] [Abstract][Full Text] [Related]
19. Unilateral whisker pad injection of botulinum toxin type a enhances spatial learning in mice.
Ni LH; Cao SX; Lian H; Hu XY
Neuroreport; 2018 Aug; 29(12):987-992. PubMed ID: 29965874
[TBL] [Abstract][Full Text] [Related]
20. A dileucine in the protease of botulinum toxin A underlies its long-lived neuroparalysis: transfer of longevity to a novel potential therapeutic.
Wang J; Zurawski TH; Meng J; Lawrence G; Olango WM; Finn DP; Wheeler L; Dolly JO
J Biol Chem; 2011 Feb; 286(8):6375-85. PubMed ID: 21138836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
